Editas Medicine Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon. My name is Gena Wang. I'm biotech analyst at Barclays. Welcome to our second Virtual Global Healthcare Conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and a corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next presenting company is Editas. With us today, we have Jim Mullen, Chief Executive Officer; Lisa Michaels, Chief Medical Officer; Michelle Robertson, Chief Financial Officer.
With that, I hand over to you, Jim, for a brief overview of the company.
Thank you very much, Gena. We're very happy to be here today. Thanks for hosting us. So let me give just a high-level overview, and then we'll go right to the questions and answers.
I think as most people know that are on this, Editas Medicine is really based on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
